[DOI] [PMC free article] [PubMed] [Google Scholar] Mahlicli F.Y., Altinkaya S.A
Eli Lilly's rival medication is expected to gain approval from regulators next year
Participants receiving semaglutide showed nearly a 50% reduction in alcohol consumptionan effect size equal to or greater than seen with FDA-approved medications for AUD, like naltrexone, acamprosate, and disulfiram
If you effectively treat obesity and reduce excess adiposity there are countless downstream positives for other health outcomes, Kelly said, listing conditions that may be affected by sustained weight loss, including type 2 diabetes, chronic kidney disease, sleep apnea, heart attack and knee osteoarthritis pain
doi: 10.1155/2021/2999296 267 LiLXFanLXZhouJXGranthamJJCalvetJPSageJet al